Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q3 FY2012 Earnings Presentation
21 slides from Apollo Hospitals Enterprise's earnings presentation, February 2012
Slide 1: Q3 FY 2012 Earnings Update
Q4 FY 2012 Earnings Update Q3 FY 2012 Earnings Update 1
Slide 2: Safe Harbour
Safe Harbour N representation No t ti or warranty,t express or implied, i li d iis made d as tto, and d no reliance li should h ld bbe placed l d on, th the ffairness, i accuracy, completeness l t or correctness of the information or opinions contained in this presentation. Such information and opin
Slide 3: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 3
Slide 4: Q3 Highlights – (1/2) Financial Performance
Q3 Highlights – (1/2) • Q3 FY12 Consolidated Revenues of Rs 8,029 mio (up 19.5% yoy) Financial Performance • Consolidated EBITDA of Rs 1,304 mio (up 25.5% yoy) • Consolidated EBITDA margin at 16.2% as compared to 15.5% in Q3 FY11 • Consolidated PAT of Rs 605 mio (up 54 54.9% 9% yoy); 7 7.5% 5% PAT m
Slide 5: Q3 Highlights – (2/2) Medical Initiatives Accomplishments
Q3 Highlights – (2/2) Medical Initiatives • Launched the Apollo Institute of Robotic Surgery in Chennai, the first world class robotic & centre in Tamil Nadu, in collaboration with the Vattikuti Foundation, USA Accomplishments • Introduced the MRI-guided High Intensity Fibroid Ultrasound (HIFU) for
Slide 6: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 6
Slide 7: Consolidated Financial Performance
Consolidated Financial Performance (Unaudited) ` Mio Q3 Q3 YTD Dec YTD Dec FY 11 FY 12 yoy (%) FY 11 FY 12 yoy (%) Income from Operations 6,365 7,561 18.8% 18,052 21,712 20.3% Add: Share of JVs 356 468 31.7% 1,097 1,399 27.6% Total Revenues 6,721 8,029 19.5% 19,149 23,111 20.7% EBITDA 1,039 1,304 25
Slide 8: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 8
Slide 9: Standalone Financial Performance – (1/2)
Standalone Financial Performance – (1/2) ` Mio Q3 Q3 YTD Dec YTD Dec Key Hi K Highlights hli h (YTDFY12) FY11 FY12 yoy (%) FY11 FY12 yoy (%) • Revenues of Rs 20,555 mio, 20.2% Revenue 6,009 7,148 19.0% 17,106 20,555 20.2% yoy growth Operative Expenses 3,328 3,874 16.4% 9,362 11,172 19.3% Employee Ex
Slide 10: Standalone Segment-wise Performance – (2/2)
Standalone Segment-wise Performance – (2/2) ` Mio Q3 Q3 YTD Dec YTD Dec Key Highlights (YTDFY12) FY11 FY12 yoy (%) FY11 FY12 yoy (%) • Healthcare services Revenues from each segment Revenues at Rs Heathcare Services * 4,277 4,903 14.6% 12,317 14,332 16.4% 14,332 mio, 16.4% yoy Stand alone Pharmacy S
Slide 11: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 11
Slide 12: Operational Performance – Hospitals
Operational Performance – Hospitals ` Mio Total (5) Chennai cluster Hyderabad cluster Others (1) Significant subs/ JVs/ associates (2) Particulars YTD Dec YTD Dec Growth yoy YTD Dec YTD Dec Growth yoy YTD Dec YTD Dec Growth yoy YTD Dec YTD Dec Growth yoy YTD Dec YTD Dec Growth yoy FY11 FY12 (%) FY11
Slide 13: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 13
Slide 14: Operational Performance – Retail Pharmacy
Operational Performance – Retail Pharmacy ` Mio Q3 Q3 YTD Dec YTD Dec Batch Particulars FY11 FY12 yoy % FY11 FY12 yoy % Upto FY No of Stores 315 299 315 299 2007 Revenue/store 2.18 2.45 12.3% 6.20 7.11 14.7% Batch EBITDA /store 0.11 0.14 24.4% 0.31 0.40 27.3% EBITDA Margin M i % 5 2% 5.2% 5 8% 5.8%
Slide 15: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 15
Slide 16: Key Hospital Expansion Plan & Update on Execution
Key Hospital Expansion Plan & Update on Execution Total Estim ated AHEL's Share Focus on owned hospitals Type of Project Cost of Cost Location CoD* Hospital No of Beds (Rs.m n) (Rs.m n) • No. of owned hospitals to increase to over 49 from Mumbai Cluster 37 N iM Navi Mumbai b i FY14 Super S Specialty
Slide 17: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 17
Slide 18: Update on non hospital JVs, Associates
Update on non hospital JVs, Associates ` Mio YTD Dec YTD Dec • Y-O-Y revenue growth of 12.7% Particulars FY11 FY12 yoy (%) • Expansion in EBITDA margins by 111 bps at Total Income 3,276 3,691 12.7% 15.2% in YTDFY12 as compared to 14.1% in YTDFY11. EBITDA 462 562 21.6% • H1FY12 PAT had one off margin
Slide 19: Q&A
Q&A 19
Slide 20: Appendix: Basis of Consolidation
Appendix: Basis of Consolidation AHEL Standalone Location Description Chennai Main Chennai Hospital ASH - Chennai Chennai Hospital Tondiarpet - Chennai Chennai Hospital FirstMed - Chennai Chennai Hospital Apollo Children's Hospital Chennai Hospital Madurai Madurai Hospital Karur Karur Hospital Karai
Slide 21: Hospitals – Understanding Key Operating Metrics
Hospitals – Understanding Key Operating Metrics Description Formula / Calculation Key Driver • Number of operating • - • Project execution Operating Beds beds • Capital Expenditure x • In-patient Bed Days • In-patient Bed Days • Brand Occupancy Billed • Doctor reputation • Quality of outcomes • Comp
Apollo Hospitals Enterprise — Q3 FY2012 Earnings Presentation on 6ix